Pluri Inc.
pluri-biotech.comAI Executive Summary
AI-powered analysis of 10-Q filing content
Pluri Inc. faces severe financial distress with Nasdaq delisting notice due to failure to meet $35M minimum value listing standard and alternative compliance requirements. The company has until July 20, 2026 to regain compliance, with significant risks to capital access and share liquidity if delisting occurs.
Red Flags Detected (4)
Nasdaq delisting notice received January 20, 2026 for failing $35M MVLS requirement
Failed all alternative listing standards including $2.5M stockholders equity and $500K net income requirements
Issuing equity compensation in lieu of cash to service providers indicates cash flow constraints
1 more red flag detected
Key Takeaways
Company faces imminent delisting risk with 180-day compliance period ending July 2026
Financial position appears severely constrained based on failure to meet multiple Nasdaq standards
2 more takeaways
Filing Overview
What This Means
Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.
Quarterly Report: Interim filing with unaudited financial data for the quarter.